Diffuse large B-cell lymphoma trials in China

In China 133 Also abroad 346

133 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.

Phase 2RecruitingTrial-stage medicine
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
Where
Xiamen
Age
18 years to 70 years
People
38
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06151080Registry updated 2025-02-19
Phase 2RecruitingTrial-stage medicine
AZA Combined With RCHOP in P53-mutated DLBCL.
Where
Xiamen
Age
18 years to 70 years
People
52
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06158399Registry updated 2025-02-19
No phaseRecruitingResearch participation
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
Where
Shanghai
Age
18 years and over
People
400
Run by
Ruijin Hospital
See details and how to joinNCT06779435Registry updated 2025-02-19
No phaseRecruitingTrial-stage medicine
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
Where
Hangzhou
Age
18 years to 75 years
People
44
Run by
Zhejiang Cancer Hospital
See details and how to joinNCT06832267Registry updated 2025-02-18
Phase 1RecruitingTrial-stage medicine
Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
Where
Hangzhou
Age
18 years to 75 years
People
52
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06464861Registry updated 2025-02-07
Phase 2Not yet recruitingTrial-stage medicine
AZA Combined with R-GemOx for Elderly DLBCL Patients
Where
Chongqing
Age
60 years to 90 years
People
80
Run by
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06778902Registry updated 2025-01-16
No phaseRecruitingResearch participation
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Where
Shanghai
Age
18 years and over
People
150
Run by
Ruijin Hospital
See details and how to joinNCT06755775Registry updated 2025-01-01
Phase 2RecruitingTrial-stage medicine
CR-CHOP+X in Previously Untreated DEL
Where
Shanghai
Age
18 years to 75 years
People
49
Run by
Ruijin Hospital
See details and how to joinNCT06701357Registry updated 2024-12-30
Phase 2Not yet recruitingTrial-stage medicine
CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)
Where
Shanghai
Age
18 years to 75 years
People
34
Run by
Ruijin Hospital
See details and how to joinNCT06750991Registry updated 2024-12-27
No phaseRecruitingResearch participation
Real-World Study of DLBCL With Different Genetic Subtypes
Where
Shanghai
Age
18 years and over
People
10,000
Run by
Ruijin Hospital
See details and how to joinNCT06026488Registry updated 2024-12-19
Phase 1/2RecruitingTrial-stage medicine
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
Where
Zhengzhou
Age
65 years and over
People
80
Run by
Mingzhi Zhang
See details and how to joinNCT06683885Registry updated 2024-11-12
No phaseNot yet recruitingResearch participation
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Where
Shanghai
Age
18 years and over
People
200
Run by
Ruijin Hospital
See details and how to joinNCT06656234Registry updated 2024-10-24
Phase 2RecruitingTrial-stage medicine
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Where
Dongguan, Guangzhou, Lanzhou, Shantou, Shenzhen, Zhaoqing, Zhuhai
Age
18 years and over
People
39
Run by
Sun Yat-sen University
See details and how to joinNCT06647940Registry updated 2024-10-22
Phase 2Not yet recruitingTrial-stage medicine
High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)
Where
Guangzhou
Age
18 years to 70 years
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT06646211Registry updated 2024-10-17
Phase 2RecruitingTrial-stage medicine
Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL
Where
Beijing
Age
14 years and over
People
240
Run by
Navy General Hospital, Beijing
See details and how to joinNCT06503263Registry updated 2024-09-19
Phase 2Not yet recruitingTrial-stage medicine
Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement
Where
Nanjing
Age
18 years to 80 years
People
40
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06594432Registry updated 2024-09-19
Phase 1RecruitingTrial-stage medicine
Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma
Where
Tianjin
Age
18 years and over
People
25
Run by
Beijing Yongtai Ruike Biotechnology Company Ltd
See details and how to joinNCT06047197Registry updated 2024-08-27
Phase 2RecruitingTrial-stage medicine
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
Where
Guangzhou
Age
18 years and over
People
38
Run by
Sun Yat-sen University
See details and how to joinNCT06569485Registry updated 2024-08-26
Phase 2RecruitingTrial-stage medicine
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
Where
Hanzhou
Age
18 years to 75 years
People
36
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06554600Registry updated 2024-08-15
Phase 3RecruitingTrial-stage medicine
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
Where
Shanghai
Age
70 years and over
People
100
Run by
Ruijin Hospital
See details and how to joinNCT06522555Registry updated 2024-08-05
Phase 2RecruitingTrial-stage medicine
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
Where
Hangzhou
Age
18 years to 65 years
People
260
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762Registry updated 2024-08-02
Phase 3RecruitingTrial-stage medicine
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Where
Beijing, Changchun, Changsha, Chaozhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Suzhou, Tianjin, Ürümqi, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
244
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06521255Registry updated 2024-07-25
Phase 1RecruitingTrial-stage medicine
An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Where
Shanghai
Age
18 years and over
People
9
Run by
Fudan University
See details and how to joinNCT06517004Registry updated 2024-07-24
No phaseNot yet recruitingResearch participation
Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
Where
Suzhou
Age
18 years and over
People
30
Run by
Second Affiliated Hospital of Soochow University
See details and how to joinNCT06289959Registry updated 2024-03-04
Phase 2RecruitingTrial-stage medicine
Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients
Where
Beijing
Age
70 years and over
People
30
Run by
Yan Zhang, MD
See details and how to joinNCT06176729Registry updated 2023-12-20

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error